NeoGenomics
Healthcare Services · Florida, United States · 1K - 5K Employees
View Company Info for Free
Overview
Headquarters
9490 Neogenomics Way, Fort Myers, Florid...Phone Number
(239) 768-0600Website
www.neogenomics.comRevenue
$766.3 MillionStock Symbol
NEOIndustry
ZI Rank: 3
Signal Type
Feb
Mar
Apr
May
Jun
Jul
ZI Rank
5
6
1
2
3
3
About NeoGenomics
NeoGenomics, Inc together with its subsidiaries, operates a network of cancer-focused genetic testing laboratories providing genetic and molecular testing services to hospitals, pathologists, oncologists, urologists, other clinicians and researchers, and other laboratories in the United States. It offers cytogenetics testing services to study normal and abnormal chromosomes and their relationship to diseases; fluorescence in-situ hybridization testing services that focus on detecting and locating the presence or absence of specific DNA sequences and genes on chromosomes; flow cytometry testing services to measure the characteristics of cell populations; immunohistochemistry and digital imaging testing services to localize proteins in cells of a tissue section, as well as to allow clients to see and utilize scanned slides, and perform quantitative analysis for various stains; and molecular testing services that focus on the analysis of DNA and RNA, and the structure and function of geneRead more
NeoGenomics Org Chart
Get the full picture
Sign in to uncover key details.
JC
Supply Chain Vice President, Global Procureme...
RK
Vice President, Quality
AC
Vice President, Clinical Programs
JM
Vice President, Enterprise & Pharma Operation...
JF
Vice President, Commercial Operations
Get the full picture
Sign in to uncover key details.
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is NeoGenomics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
NeoGenomics, which may be a good buyer, showed buying intent in Masked Content Topic
Congratulate Masked Content for being promoted to Masked Content at NeoGenomics
Check if NeoGenomics has recently received funding, and reach out quickly before it becomes old news!
Check out if NeoGenomics is spiking on competitors!
Product Launch: Get notified when NeoGenomics launches new products
Click to see if NeoGenomics had a recent Job posting/layoffs
Website visits: Recent activity has been detected on your website
Earning: See what the market has to say on NeoGenomics recently announced quarterly report
Funding: Get notified immidiatlly once NeoGenomics has new funding data
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Recommended Actions
Find VP level buyers at NeoGenomics
Find more new buyers
Compare Similar Companies to NeoGenomics
Compare insights from companies similar to NeoGenomics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
$232.5M
1K - 5K
Public
$195.5M
2010
EL
Ewa Lipinska-KowalikSenior Executive Administartive Partner To CEO
Company Profile Activity
Activity Insights
NeoGenomics is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
NeoGenomics is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about NeoGenomics.
NeoGenomics Tech Stack
A closer look at the technologies used by NeoGenomics
See more technologies
Most Recent Scoops
Earnings
NeoGenomics has reported non-clinical revenue of $14.5 million for Q2, a decline of 15% year-over-year, with pharma revenue declining 26%, partially offset by 17% growth in the oncology data solutions business.
Earnings, Pharmaceuticals, Finance
Earnings
NeoGenomics has reported adjusted gross margin expansion of 260 basis points year-over-year for the quarter, driven primarily by 12% AUP growth and efficiencies from its Lab of the Future initiative, while operating expense discipline contributed to 36% growth in adjusted EBITDA.
Earnings, Finance, Financial Operations
Earnings
NeoGenomics has reported an adjusted gross margin of 48.1% for Q2, an expansion of approximately 260 basis points versus the prior period, with adjusted gross profit increasing $14.5 million, or 18%, year-over-year to $96.9 million, driven by AUP growth, volume leverage, and Lab of the Future efficiencies.
Earnings, Finance
Earnings
NeoGenomics has reported ending Q2 with $145.5 million in cash and cash equivalents, while having strengthened its capital structure by extending its convertible debt maturity from 2028 to 2032.
Earnings, Finance, Financing & Debt
Earnings
Earnings, Finance
NeoGenomics News & Media
NeoGenomics Inc (NEO) Q2 2026 Earnings Call Highlights: Strong Revenue Growth and Raised ...
NeoGenomics Inc (NEO) reports robust revenue growth and margin expansion, while addressing challenges in its pharma segment and raising full-year guidance.NeoGenomics, Inc. (NEO) Q2 2026 Earnings Call Transcript
NeoGenomics, Inc. (NEO) Q2 2026 Earnings Call July 28, 2026 4:30 PM EDTCompany ParticipantsAbhishek Jain - Executive VP & CFOAndrew BrackmannAnthony...NeoGenomics Q2 Earnings Call Highlights
NeoGenomics (NASDAQ:NEO) raised its full-year 2026 revenue and adjusted EBITDA guidance after reporting second-quarter revenue growth that exceeded its prior outlook, led by higher-value clinical testing and continued expansion in next-generation sequencing. Total second-quarter revenue rose 11% yeNeoGenomics Laboratories to Pay $9.8 Million to Resolve FCA Allegations Relating to ...
Headlines that Matter for Companies and Executives in Regulated Industries
Read more news
Top Healthcare Services Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding NeoGenomics
Sign Up For FreeTo access detailed company insights
NeoGenomics, Inc together with its subsidiaries, operates a network of cancer-focused genetic testing laboratories providing genetic and molecular testing services to hospitals, pathologists, oncologists, urologists, other clinicians and researchers, and other laboratories in the United States. It offers cytogenetics testing services to study norma... Read More
